Medical Cannabis Reviews & The Hemp Happy network supports the Research, Political Canvassing, Seminars, Activities and the ongoing Education from the “Non -For-Profit”
Medical Cannabis Research
In February 2016 legislation (Narcotics Amendment Bill 2016) to legalise medical cannabis in Australia passed through federal Australian parliament in record time. It was supported by all sides of politics. This means as at 1 November 2016 Australian patients with certain serious medical conditions and under strict controls will be able to access these products through medical professionals.
Cannabis has been used as a medicine since ancient times. In modern history it was used extensively in pharmacy formulations in the early 19th century.
Cannabis used as a medicine has made a resurgence in recent years and is now legal in a number of parts of the world. Whilst anecdotal cases are plentiful scientific studies are still being undertaken to determine the effectiveness in certain disease states. The main ones we are studying below:
Medical Cannabis Research Australia was established in December 2016 by Paul and Sharlene Mavor and Tony Hume.
Paul Mavor is a pharmacist and has practiced for over 26 years in WA and owned a number of pharmacies. He has an interest in the pharmacokinetics of different cannabis dosage forms.
Sharlene Mavor is a medical scientist with majors in Microbiology, Virology and Biotechnology. She has worked in a number of laboratories both in Western Australia and in the UK. Sharlene has a particular interest in different cannabis strains, potency and purity testing and extraction methods.
Tony Hume is an experienced fund raiser and has a diverse background in education, health and philanthropy. He is a graduate of the Australian Institute of Company Director’s course and is accredited as a Certified Fundraising Executive (CFRE) world-wide. Tony also is an Independent Director for the Yinhawangka people in the Eastern Pilbara region. He is passionate about positive community impact and making connections in the community to maximise peoples’ opportunities.
Medical Cannabis Research Australia is committed to improve the lives of Australian persons and families by reducing the suffering, prevalence and impact of a variety of diseases through the use of medical cannabis. This will be achieved with a focus on clinical trials and ethical supply of medical cannabis. Research will be conducted to support and promote public awareness for the use of medical cannabis including education for clinical practitioners with new treatment options, both locally and globally for their patients. We aim to educate and advise health professionals, patients, their families and carers in the use of medical cannabis through media, education and fund raising campaigns and further cooperate with government and likeminded organisations in order to advance the research, treatments, equity and quality of life which can be assisted with the use of medical cannabis.
Clinical Studies are underway in several states of Australia
These are largely government sponsored
NSW – terminal cancer – vaporised THC vs THC+CBD
-paediatric epilepsy – cannabidivarin, CBD
-Chemotherapy induced nausea and vomiting – THC + CBD
QLD – cannabis oil in paediatric epilepsy
ACT – cannabis for melanoma
Vic – paediatric epilepsy – synthetic cannabidiol
CBD is short or Cannabidiol which by all scientific accounts
appears to be the ROCKSTAR of the Cannabinoid world.
It is the most predominant Cannabinoid in Hemp and is
endowed with many beneficial properties.
In its patent (#6,630,507) titled CANNABINOIDS AS
ANTIOXIDANTS AND NEUROPROTECTANTS^ the US
Government makes many impressive claims about CBD
including the following: “Cannabidiol (CBD), a
naturally-occurring constituent of the industrial hemp
plant, promotes and supports the nutritional health of
One of the properties of CBD is that it is anti-psychoactive
which means that unlike THC, the Cannabinoid found
abundantly in Marijuana, CBD is not psychoactive and may
be consumed safely as a dietary supplement.
It simply is not possible to get “high” or
intoxicated by consuming Industrial Hemp food products.
It is safe or the whole family.
THE ILLEGAL MIRACLE part 1 from Elixinol CBD Hemp Oil
MEDICINAL cannabis has been made legal in Victoria and will be grown and supplied to patients in Victoria as early as 2017.
The historic Access to Medicinal Cannabis Bill 2015 passed the Victorian parliament just after 6pm.
Children suffering severe epilepsy will be among the first to be treated using a range of non-smokable marijuana products including oils, sprays and vaporisers.
Minister for Health Jill Hennessy welcomed the bill passing.
“Children with severe epilepsy will now be able to legally access this lifesaving treatment from as early as 2017.”
Recent medical research suggests that the use of medical marijuana could play a significant role in reducing the progression of the dreaded Alzheimer’s disease. Tetrahydrocannabinol or THC that is its primary ingredient reduces and prevents the formation of neural protein deposits deep within the brain. These deposits are primarily responsible for this degenerative neural condition. Medical cannabis that is supplied supplied by medical marijuana dispensaries control the formation of these protein deposits or sticky amyloid plaques that result in neuronal damage, inhibits memory and cognition, cause severe loss of memory, and lead to confusion, irritability, mood swings, spatial disorientation, and speech problems.
The progressive and fatal Alzheimer’s disease destroys brain cells, which results in loss of memory, dementia, and disturbed motor skills along with diminished intellect and social skills. Alzheimer’s disease is among the top ten causes of death in the elderly in the United States. Research indicates that medical cannabis represents an effective drug treatment for Alzheimer’s disease and some of its symptoms.
While Medical Marijuana (MMJ) is legal in some cities of the United States, it is mandatory that all MMJ card holders obtain Medical Cannabis at legal the dispensary. A MMJ dispensary can also guide a patient in the process of obtaining their medical marijuana card.
Alzheimer’s disease is a degenerative condition that is marked by a continuous decline in memory and intellectual facility. It is incurable and terminal and usually affects people over 65 years of age. MMJ reduces the production of the neural enzyme acetylcholinesterase that triggers the formation of harmful protein deposits in the brain and lowers the level of the important neurotransmitter called acetylcholine.
While alcohol, heroin, cocaine and nicotine suppress and inhibit the growth of new brain cells, recent clinical studies by the San Diego based Scripps Research shows that marijuana promotes the growth of neurons. It is this property that strongly supports its medicinal use along with controlled and monitored distribution through various medical marijuana dispensaries.
There are a number of prescription drugs too that are known to stifle the growth of new brain cells. Apart from doing exactly the opposite, medical cannabis from the dispensaries decreases the growth of tumors and inflammation in clinical trials conducted on nearly 50% of patients afflicted with lung cancer. Patients find immense relief from their symptoms of Alzheimer’s through a licensed dispensary that supplies them with optimal doses of Medical Marijuana to cope with their symptoms.
Article Directory: http://www.articledashboard.com
Colorado is one of the states that has legalized Medical Marijuana for use as a medicine.
How safe is MEDICAL CANNABIS?
Cannabinoids possess a remarkable safety record, particularly when compared to other therapeutically active substances, particularly prescription drugs. Most significantly, the consumption of marijuana — regardless of quantity or potency — cannot induce a fatal overdose.
What it can do to you
Investigators are also studying the anti-cancer activities of cannabis, as a growing body of preclinical and clinical data concludes that cannabinoids can reduce the spread of specific cancer cells via apoptosis (programmed cell death) and by the inhibition of angiogenesis (the formation of new blood vessels).
• Several of studies conducted by the University of California Center for Medicinal Cannabis Research assessed smoked marijuana’s ability to alleviate neuropathic pain, a notoriously difficult to treat type of nerve pain associated with cancer, diabetes, HIV/AIDS, spinal cord injury and many other debilitating conditions. Each of the trials found that cannabis consistently reduced patients’ pain levels to a degree that was as good or better than currently available medications.
• University of California Center for Medicinal Cannabis Research publicly announced the findings of a series of randomized, placebo-controlled clinical trials on the medical utility of inhaled cannabis. The studies, which utilized the so-called ‘gold standard’ FDA clinical trial design, concluded that marijuana ought to be a “first line treatment” for patients with neuropathy and other serious illnesses.
• Of particular interest, scientists are investigating cannabinoids’ capacity to moderate autoimmune disorders such as multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease, as well as their role in the treatment of neurological disorders such as Alzheimer’s disease and amyotrophic lateral sclerosis (a.k.a. Lou Gehrig’s disease.)
• In 2009, the American Medical Association (AMA) resolved “that marijuana’s status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines.”
The scientific conclusions of the overwhelmingly majority of modern research directly conflicts with the US federal government’s stance that cannabis is a highly dangerous substance worthy of absolute criminalization.